Immunovant, Inc.
Immunovant, Inc. (IMVT) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · IMVT · as of Jun 8, 2026
Activity summary
Buy transactions
1
P-Purchase only
Sell transactions
38
12 Months
Buy/Sell ratio
0.03
Buy/Sell (by trades)
Overall sentiment
Immunovant, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
IMVT insider buying and selling by quarter
IMVT insider selling · IMVT insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · IMVT ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
IMVT executive sell shares · IMVT board member insider trading · IMVT insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 28, 2026 | Fromkin Andrew J. Director | Option | 16,260 | $239K | Form 4 |
| May 28, 2026 | Fromkin Andrew J. Director | Sale | 11,483 | $375K | Form 4 |
| May 28, 2026 | Fromkin Andrew J. Director | Option | 77,181 | $651K | Form 4 |
| May 28, 2026 | Fromkin Andrew J. Director | Option | 71,492 | $568K | Form 4 |
| May 28, 2026 | Fromkin Andrew J. Director | Option | 31,668 | $158K | Form 4 |
| May 28, 2026 | Fromkin Andrew J. Director | Sale | 210,468 | $7.06M⚡ | Form 4 |
| May 20, 2026 | Gloria Melanie COO | Sale | 249 | $8K | Form 4 |
| May 20, 2026 | Gloria Melanie COO | Sale | 1,168 | $38K | Form 4 |
| May 20, 2026 | Gloria Melanie COO | Sale | 1,698 | $56K | Form 4 |
| May 20, 2026 | Pande Atul Director | Option | 6,000 | $51K | Form 4 |
| May 20, 2026 | Pande Atul Director | Sale | 6,000 | $192K | Form 4 |
| May 1, 2026 | Susman Robert Graham Director | Sale | 2,502 | $68K | Form 4 |
| Apr 23, 2026 | Girao Tiago CFO | Sale | 25,760 | $763K | Form 4 |
| Apr 23, 2026 | Stout Jay S CTO | Sale | 2,754 | $82K | Form 4 |
| Apr 8, 2026 | Van Tuyl Christopher Chief Legal Officer | Sale | 5,165 | $128K | Form 4 |
| Apr 8, 2026 | Gloria Melanie COO | Sale | 8,722 | $217K | Form 4 |
| Apr 8, 2026 | Stout Jay S CTO | Sale | 8,614 | $214K | Form 4 |
| Apr 8, 2026 | Stout Jay S CTO | Sale | 1,518 | $38K | Form 4 |
| Apr 7, 2026 | Torti Frank Director | Award | 174,189 | — | Form 4 |
| Apr 7, 2026 | Fromkin Andrew J. Director | Award | 13,880 | — | Form 4 |
| Apr 7, 2026 | Hughes Douglas J. Director | Award | 13,880 | — | Form 4 |
| Apr 7, 2026 | Pande Atul Director | Award | 13,880 | — | Form 4 |
| Apr 7, 2026 | Bauer Jake Director | Award | 13,880 | — | Form 4 |
| Apr 7, 2026 | Susman Robert Graham Director | Award | 13,880 | — | Form 4 |
| Apr 7, 2026 | Gloria Melanie COO | Award | 83,671 | — | Form 4 |
Van Tuyl Christopher
Chief Legal Officer
Date
Apr 8
Shares
5,165
Price
$24.83
Value
$128K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About IMVT insider trading
IMVT insider trades
Immunovant, Inc. (IMVT) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Stout Jay S (CTO), Gloria Melanie (COO), Fromkin Andrew J. (Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. IMVT insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Immunovant, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
IMVT insider trading · 5 questionsThe insiders of Immunovant, Inc. (IMVT) include executives and directors such as Stout Jay S (CTO), Gloria Melanie (COO), Fromkin Andrew J. (Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026